Endocrinology

Top Story

Trial for oral semaglutide announced

September 5, 2015

Novo Nordisk recently announced its decision to begin a phase 3a program with an oral formulation of the GLP-1 analogue semaglutide, following results of the proof-of-concept phase 2 trial, according to a company press release.

The program, named PIONEER, will include seven trials with about 8,000 people with type 2 diabetes. The studies will include six safety and efficacy trials and one trial to evaluate the cardiovascular safety of the drug.

In the Journals

Five effects of hormone therapy

September 4, 2015
Endocrine Today has compiled a list of some recent research on the effects of hormone therapy. Healio.com/Endocrinology readers were informed about the impacts of…
In the Journals

Children with type 1 diabetes can safely delay vision screenings

September 4, 2015
Eye screenings for diabetic retinopathy in children with type 1 diabetes should begin at age 15 years or 5 years after diabetes diagnosis, whichever comes later…
In the Journals

Long-term diabetes control better with surgery than standard therapy

September 4, 2015
More effective control of type 2 diabetes in patients was found with metabolic or bariatric surgery compared with standard medical treatments, according to recent study…
In the Journals

NAFLD prevalent in adolescents undergoing bariatric surgery

September 4, 2015
In the Teen-Longitudinal Assessment of Bariatric Surgery study, researchers found that more than half of obese adolescents undergoing bariatric surgery had nonalcoholic…
More News Headlines »
CME
Assessing Cornerstones for Successful Weight Loss

Assessing Cornerstones for Successful Weight Loss: Building a Foundation that Really Works

This activity is supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc.

Obesity has increased dramatically in the past 2 decades and is now considered a health care epidemic in the United…
More »
Meeting News Coverage Video
VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

VIDEO: Chef integrates food and medicine in promotion of cardiometabolic health

August 10, 2015
NEW ORLEANS — Chef Leah Sarris, program director at the Goldring Center for Culinary Medicine at Tulane…
More »
CME
Real-world Use of Anti-VEGF Therapy

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Current Issues
View the Current Issues
morganatic-roan